| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 13,291 | 12,644 | 11,133 | 12,126 | | Cost of Revenue | 4,286 | 4,666 | 3,461 | 3,928 | | | Gross Profit | 9,005 | 7,978 | 7,672 | 8,199 | | | Operating Expenses | | Research Development | 3,302 | 3,636 | 3,310 | 3,561 | | Selling General and Administrative | 9,945 | 10,995 | 11,492 | 11,027 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,242) | (6,653) | (7,129) | (6,389) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (486) | 309 | 278 | 29 | | Earnings Before Interest And Taxes | (4,728) | (6,344) | (6,851) | (6,360) | | Interest Expense | 1,085 | 1,096 | 679 | 1,132 | | Income Before Tax | (5,814) | (7,440) | (7,530) | (7,492) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,814) | (7,440) | (7,530) | (7,492) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,814) | (7,440) | (7,530) | (7,492) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,814) | ($7,440) | ($7,530) | ($7,492) |
|
0.51% Nasdaq 
0.03 (0.74%) 
Income Statement
